Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.

Current Report (Form 8-K | Period ending 2024-06-05)

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Penumbra (PEN US)

Current Report (Form 8-K | Period ending 2024-06-05)

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

Current Report (Form 8-K | Period ending 2024-05-07)

Annual Report to Security Holders (Form ARS | Period ending 2023-12-31)

Current Report (Form 8-K | Period ending 2024-03-17)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)